Cyclo (RGDyK) trifluoroacetate
Cyclo (RGDyK) trifluoroacetate is a selective αVβ3 integrin antagonist with an IC50 of 20 nM. This cyclic RGD peptide is widely used in vitro and in vivo to study angiogenesis, tumor metastasis, and osteoporosis by blocking integrin-mediated cell adhesion and signaling pathways.
Product Specifications
Product Name Alternative
Cyclo (RGDyK), Cyclo (RGDyK) trifluoroacetate, Cyclo (RGDyK) Trifluoroacetate, Inhibitor, Integrin, inhibit, αVβ3 integrin
Field of Research
Signal Transduction
Purity
≥95% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (4.72 mM) ; DMSO:130 mg/mL (153.35 mM)
Molecular Weight
847.72
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog